Circulating trimethylamine <i>N</i>‐oxide levels do not predict 10‐year survival in patients with or without coronary heart disease

Abstract

Circulating TMAO did not predict long-term all-cause, CV, or non-CV mortality in patients with coronary heart disease or in community-based adults. This large study does not support a role of TMAO for patient risk stratification in primary or secondary prevention.